Biotechnology
Spectrum Pharmaceuticals Announces Phase 2 Trial of Poziotinib
Last week, Spectrum Pharmaceuticals, Inc. (NASDAQ:$SSPI), announced the initiation of a Phase 2 trial of poziotinib in non-small cell lung cancer patients with Exon 20 insertion mutation in EGFR or HER2. The biotechnology company runs ... [Read]
Biotechnology
Zacks Investment Research Upgrades VBI Vaccines, Inc. to ‘Hold’
A report on Tuesday from Zacks Investment Research upgraded VBI Vaccines (NASDAQ:$VBIV), Inc from a ‘Sell’ to a ‘Hold’ rating. VBI Vaccines is a biotechnology company that specializes in developing vaccines and antigens for issues ... [Read]
Biotechnology
Spectrum Pharmaceuticals Inc. Sees Price Target Raised by Jefferies Group LLC
In a research note from Monday, Jefferies Group LLC (NYSE:$JEF) raised its target price for Spectrum Pharmaceuticals Inc. (NASDAQ:$SPPI) stock from $13.00 to $18.00. This would indicate a potential upside of 26.05% from the company’s ... [Read]
Biotechnology
Jefferies Group Issues Forecast for Spectrum Pharmaceuticals for Q3 2017
On Monday, Jefferies Group analysts listed their Q3 forecasts for Spectrum Pharmaceuticals Inc. (NASDAQ:$SPPI) stock. Analyst M. Andrews says the stock will likely increase from the prior quarter’s -$0.18 EPS and reach an EPS of -$0.16. ... [Read]
Biotechnology
Zacks Investment Research Upgrades VBI Vaccines’ Rating
In a report published on Tuesday morning, Zacks Investment Research has upgraded its rating of VBI Vaccines, Inc (NASDAQ:$VBIV) from a ‘Sell’ rating to a ‘Hold’. VBIV is a biotechnology company that is focused on ... [Read]
Biotechnology
VBI Vaccines Inc and Its Technical Indicators
VBI Vaccines Inc (NASDAQ:$VBIV) may have caught the attention of investors when the SuperTrend line crossed above the current stock price recently. This indicator may signal that the stock may soon enter ‘Buy’ territory. The ... [Read]
Biotechnology
VBI Vaccines, Inc.: What Can We Learn From Indicators and Metrics?
VBI Vaccines (NASDAQ:$VBIV) is a healthcare company specializing in the biotechnology industry. They have seen relatively little movement over the past month. So what can the technical indicators tell us about this pharmaceutical company? Let’s ... [Read]
Biotechnology
Head-to-Head: Spectrum Pharmaceuticals VS PTC Therapeutics
Two healthcare companies hitting new highs recently are Spectrum Pharmaceuticals (NASDAQ:$SPPI) and PTC Therapeutics (NASDAQ:$PTCT). However, where do you start when weighing them against each other? Let’s look at the stats. Spectrum Pharmaceuticals is a ... [Read]
Biotechnology
Versartis Shares Plunged a Whopping 82% Today
Versartis Inc. (NASDAQ:$VSAR) shares plunged a whopping 82% late Thursday. Why? It all started after the California-based biopharmaceutical company announced that its drug Somavaratan failed to meet its endpoint in a phase 3 trial. The ... [Read]
Biotechnology
Intercept Pharmaceuticals Plunged Today, Here’s Why
On Thursday, September 21, as of 3:26 p.m. EDT, Intercept Pharmaceuticals (NASDAQ:$ICPT) plunged 21%. What happened? Well, the fall began after the FDA released a safety announcement warning the public that when Intercept’s liver disease ... [Read]